Companies / Standard Biotools Inc.
Standard Biotools Inc.
Nasdaq: LABCIK 1162194BOSTON, MA
Financials · FY2025
Ownership
392.6M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 3.98% | 15,620,478 |
| 10%+ / strategic | 5.09% | 19,967,565 |
| Institutions | 73.19% | 287,317,440 |
| Public float | 17.75% | 69,673,325 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Egholm MichaelCEOPresident & CEO · Director | 1.68% | 6,597,956 |
Casdin EliDirector · 10% owner | 0.78% | 3,053,169 |
Kim Hanjoon AlexChief Financial Officer | 0.70% | 2,760,530 |
Mackay SeanSVP & Chief Business Officer | 0.38% | 1,506,552 |
Cox TroyDirector | 0.12% | 475,702 |
Carey Thomas D.Director | 0.09% | 344,456 |
Eloi Fenel MDirector | 0.09% | 335,299 |
Witney FrankDirector | 0.08% | 309,978 |
Hibbs Kathy LDirector | 0.06% | 236,836 |
Institutional holders 162
View all →| Holder | Value | % of shares |
|---|---|---|
| $113.64M | 22.62% | |
| $53.92M | 14.94% | |
| $24.06M | 6.67% | |
| $22.14M | 4.41% | |
| $16.23M | 3.23% | |
| $9.85M | 1.96% | |
| $7.11M | 1.41% | |
| $6.79M | 2.10% | |
| $6.70M | 1.86% | |
| $5.91M | 1.18% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | Egholm Michael CEO | Other | Common Stock | $97.6K | -98K -1.46% | 6,597,956 1.68% of shares | low |
| Apr 6, 2026 | Egholm Michael CEO | Other | Common Stock | $86.3K | -95K -1.40% | 6,695,582 1.71% of shares | low |
| Feb 23, 2026 | Egholm Michael CEO | Other | Common Stock | $76.0K | -66K -1.18% | 5,551,710 1.41% of shares | low |
| Feb 26, 2026 | Cox Troy Director | Grant | Common Stock | $67.0K | +57K +17.93% | 376,586 0.10% of shares | low |
| Feb 26, 2026 | Casdin Eli Director | Grant | Common Stock | $62.0K | +53K +1.83% | 2,954,053 0.75% of shares | low |
| Feb 26, 2026 | Carey Thomas D. Director | Grant | Common Stock | $60.0K | +51K +26.43% | 245,340 0.06% of shares | low |
| May 20, 2026 | Mackay Sean Executive | Other | Common Stock | $25.7K | -26K -2.49% | 1,006,552 0.26% of shares | low |
| Feb 23, 2026 | Mackay Sean Executive | Other | Common Stock | $22.6K | -20K -2.52% | 760,174 0.19% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| MAK Capital Fund LP | Passive13G | — |
| Viking Global Investors LP | Passive13G/A | — |
| MAK Capital Fund LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| LAB | — | 34385P108 |